Cullinan Oncology shares owned by T. Rowe Price Associates
Quarter-by-quarter ownership of Cullinan Oncology (CGEM) shares owned by T. Rowe Price Associates
from 13F filings
Historical chart of T. Rowe Price Associates investment in Cullinan Oncology
Tip: Access up to 7 years of quarterly data
All positions including Cullinan Oncology held by T. Rowe Price Associates consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Cullinan Oncology by T. Rowe Price Associates
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $29M | 2.0M | 14.21 |
| 2025-12-31 | $489k | 47k | 10.36 |
| 2025-09-30 | $257k | 43k | 5.94 |
| 2025-06-30 | $275k | 36k | 7.55 |
| 2025-03-31 | $241k | 32k | 7.60 |
| 2024-12-31 | $360k | 30k | 12.21 |
| 2024-09-30 | $429k | 26k | 16.78 |
| 2024-06-30 | $363k | 21k | 17.45 |
| 2024-03-31 | $390k | 23k | 17.07 |
| 2023-12-31 | $225k | 22k | 10.22 |
| 2023-09-30 | $131k | 14k | 9.10 |
| 2023-06-30 | $155k | 14k | 10.76 |
| 2023-03-31 | $144k | 14k | 10.26 |
| 2022-12-31 | $148k | 14k | 10.53 |
| 2022-03-31 | $116k | 11k | 10.43 |
| 2021-12-31 | $164k | 11k | 15.43 |
| 2021-03-31 | $30M | 724k | 41.67 |